Accurate and efficient description of protein vibrational dynamics: Comparing molecular dynamics and Gaussian models

Current all‐atom potential based molecular dynamics (MD) allows the identification of a protein's functional motions on a wide‐range of timescales, up to few tens of nanoseconds. However, functional, large‐scale motions of proteins may occur on a timescale currently not accessible by all‐atom potential based MD. To avoid the massive computational effort required by this approach, several simplified schemes have been introduced. One of the most satisfactory is the Gaussian network approach based on the energy expansion in terms of the deviation of the protein backbone from its native configuration. Here, we consider an extension of this model that captures in a more realistic way the distribution of native interactions due to the introduction of effective side‐chain centroids. Since their location is entirely determined by the protein backbone, the model is amenable to the same exact and computationally efficient treatment as previous simpler models. The ability of the model to describe the correlated motion of protein residues in thermodynamic equilibrium is established through a series of successful comparisons with an extensive (14 ns) MD simulation based on the AMBER potential of HIV‐1 protease in complex with a peptide substrate. Thus, the model presented here emerges as a powerful tool to provide preliminary, fast yet accurate characterizations of protein near‐native motion. Proteins 2004. © 2004 Wiley‐Liss, Inc.

[1]  S. Chandrasekhar Stochastic problems in Physics and Astronomy , 1943 .

[2]  E. Dodds Vitamins and Hormones Advances in Research and Applications , 1949, Nature.

[3]  Choh Hao Li Vitamins and hormones : advances in research and applications , 1956 .

[4]  H. C. Corben,et al.  Classical Mechanics (2nd ed.) , 1961 .

[5]  M. Karplus,et al.  The hinge-bending mode in lysozyme , 1976, Nature.

[6]  J. W. Humberston Classical mechanics , 1980, Nature.

[7]  M Karplus,et al.  Time dependence of atomic fluctuations in proteins: analysis of local and collective motions in bovine pancreatic trypsin inhibitor. , 1982, Biochemistry.

[8]  Tosiyuki Noguti,et al.  Collective variable description of small-amplitude conformational fluctuations in a globular protein , 1982, Nature.

[9]  G. Lipari Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules , 1982 .

[10]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results , 1982 .

[11]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[12]  M. Karplus,et al.  Normal modes for specific motions of macromolecules: application to the hinge-bending mode of lysozyme. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Levitt,et al.  Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme. , 1985, Journal of molecular biology.

[14]  M. Karplus,et al.  Proteins: A Theoretical Perspective of Dynamics, Structure, and Thermodynamics , 1988 .

[15]  William H. Press,et al.  Numerical recipes , 1990 .

[16]  N Go,et al.  Projection of monte carlo and molecular dynamics trajectories onto the normal mode axes: Human lysozyme , 1991, Proteins.

[17]  P. Wolynes,et al.  The energy landscapes and motions of proteins. , 1991, Science.

[18]  García,et al.  Large-amplitude nonlinear motions in proteins. , 1992, Physical review letters.

[19]  A. Wlodawer,et al.  Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.

[20]  D. ben-Avraham,et al.  Normal mode analysis of G-actin. , 1993, Journal of molecular biology.

[21]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[22]  U. Hobohm,et al.  Enlarged representative set of protein structures , 1994, Protein science : a publication of the Protein Society.

[23]  D. Case Normal mode analysis of protein dynamics , 1994 .

[24]  D. Ho,et al.  Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor , 1995, Journal of virology.

[25]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[26]  M. Levitt,et al.  Energy functions that discriminate X-ray and near native folds from well-constructed decoys. , 1996, Journal of molecular biology.

[27]  D. Ho,et al.  Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease , 1996, Antimicrobial agents and chemotherapy.

[28]  Tirion,et al.  Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis. , 1996, Physical review letters.

[29]  D. Ho,et al.  Ordered accumulation of mutations in HIV protease confers resistance to ritonavir , 1996, Nature Medicine.

[30]  Rational approaches to resistance: using saquinavir. , 1996, AIDS.

[31]  B. Tidor Molecular dynamics simulations , 1997, Current Biology.

[32]  A. Atilgan,et al.  Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. , 1997, Folding & design.

[33]  P. Lam,et al.  Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities. , 1998, Biochemistry.

[34]  K. Hinsen Analysis of domain motions by approximate normal mode calculations , 1998, Proteins.

[35]  A. Atilgan,et al.  Vibrational Dynamics of Folded Proteins: Significance of Slow and Fast Motions in Relation to Function and Stability , 1998 .

[36]  B. Korber,et al.  Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy. , 1999, AIDS research and human retroviruses.

[37]  I. Bahar,et al.  Structure‐based analysis of protein dynamics: Comparison of theoretical results for hen lysozyme with X‐ray diffraction and NMR relaxation data , 1999, Proteins.

[38]  AMPRENAVIR : A PROTEASE INHIBITOR FOR THE TREATMENT OF PATIENTS WITH HIV-1INFECTION , 1999 .

[39]  A. Amadei,et al.  On the convergence of the conformational coordinates basis set obtained by the essential dynamics analysis of proteins' molecular dynamics simulations , 1999, Proteins.

[40]  R L Jernigan,et al.  Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function. , 1999, Journal of molecular biology.

[41]  Ivet Bahar,et al.  Dynamics of proteins predicted by molecular dynamics simulations and analytical approaches: Application to α‐amylase inhibitor , 2000, Proteins.

[42]  S. Gulnik,et al.  HIV protease: enzyme function and drug resistance. , 2000, Vitamins and hormones.

[43]  J R Banavar,et al.  Learning effective amino acid interactions through iterative stochastic techniques , 2000, Proteins.

[44]  D. Jacobs,et al.  Protein flexibility predictions using graph theory , 2001, Proteins.

[45]  R. Jernigan,et al.  Anisotropy of fluctuation dynamics of proteins with an elastic network model. , 2001, Biophysical journal.

[46]  J. Howard,et al.  Mechanics of Motor Proteins and the Cytoskeleton , 2001 .

[47]  J R Banavar,et al.  Conformations of proteins in equilibrium. , 2001, Physical review letters.

[48]  Amos Maritan,et al.  Elastic properties of proteins: insight on the folding process and evolutionary selection of native structures. , 2002, Journal of molecular biology.

[49]  Michele Parrinello,et al.  Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease. , 2002, Journal of molecular biology.

[50]  B. Hess Convergence of sampling in protein simulations. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[51]  Alessandro Flammini,et al.  Crucial stages of protein folding through a solvable model: Predicting target sites for enzyme‐inhibiting drugs , 2002, Protein science : a publication of the Protein Society.

[52]  J. Berg,et al.  Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.

[53]  Ursula Rothlisberger,et al.  Drug resistance in HIV‐1 protease: Flexibility‐assisted mechanism of compensatory mutations , 2002, Protein science : a publication of the Protein Society.

[54]  Robert L. Jernigan,et al.  Dynamics of large proteins through hierarchical levels of coarse‐grained structures , 2002, J. Comput. Chem..

[55]  Robert L. Jernigan,et al.  Important Fluctuation Dynamics of Large Protein Structures Are Preserved upon Coarse-Grained Renormalization ∗ , 2002 .

[56]  B. Halle,et al.  Flexibility and packing in proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Charles L Brooks,et al.  Correlated motion and the effect of distal mutations in dihydrofolate reductase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  E. Camouzis,et al.  On the Dynamics of , 2003 .

[59]  P. Carloni,et al.  Molecular dynamics simulations of the NGF-TrkA domain 5 complex and comparison with biological data. , 2003, Biophysical journal.

[60]  Turkan Haliloglu,et al.  Cooperative fluctuations of unliganded and substrate‐bound HIV‐1 protease: A structure‐based analysis on a variety of conformations from crystallography and molecular dynamics simulations , 2003, Proteins.

[61]  Ursula Rothlisberger,et al.  Reaction Mechanism of HIV-1 Protease by Hybrid Car-Parrinello/Classical MD Simulations , 2004 .